» Download Public Reports
87 reports
- Company report
- April 2012
- 5 pages
... Hospital expansion and upgrade are our favored sub-sectors. We see growth acceleration in 2012-14 the growth of the medical devices sector has been lower than the healthcare sector in the past few years ...
February 2012
... Officer, corp orate controller and treasu. He also served as president of coopervision, inc., A subsidiary of cooper, which is the third largest contact lens company in the world. Under ...
January 2012
... Authorities as part of the regulatory process q1 highlights agenda Business areas and highlights Q1 financials Beta-glucans advanced wound care Enzymes Molecular testing Summary ...
December 2011
... Property tax incentives approved for specialty foods distributor and medical supply manufactu property tax incentives approved by city council today will help revitalize a pair of vacant industrial ...
December 2011
... The cardiac rhythm management business unit (implantable devices to manage cardiac rhythm disorders) reported revenues of 70.4 Million, a 2.7%* Decrease over the fourth quarter 2010. With the commercial ...
» Purchase Premium Reports
(From $ 100 - $ 23 520)
About 1 000 reports
- $ 29 400
- Industry report
- March 2012
- by Venture Planning Group
During the next decade, the clinical chemistry and immunodiagnostics markets will undergo significant transformation. The changes will be caused convergence of new and more stringent regulations; advances ...
April 2012
$ 28 700
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, ...
March 2012
$ 28 700
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, ...
February 2012
$ 28 700
Complete report $28,700.  . This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the ...
March 2012
$ 28 500
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the ...
March 2012
$ 28 500
The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next ten years will witness significant developments in reagent systems and ...
April 2012
$ 28 400
This report will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the hematology and flow cytometry markets during the next ten years. The report explores ...